bromfenacoum and Hematuria

bromfenacoum has been researched along with Hematuria* in 8 studies

Reviews

1 review(s) available for bromfenacoum and Hematuria

ArticleYear
Superwarfarin poisoning: a significant public health problem.
    Journal of community health, 1994, Volume: 19, Issue:1

    Topics: 4-Hydroxycoumarins; Abdominal Pain; Adult; Ecchymosis; Epistaxis; Female; Hematemesis; Hematoma; Hematuria; Humans; Male; Public Health; Rodenticides; Social Problems

1994

Other Studies

7 other study(ies) available for bromfenacoum and Hematuria

ArticleYear
An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.
    The New England journal of medicine, 2018, 09-27, Volume: 379, Issue:13

    In March and April 2018, more than 150 patients presented to hospitals in Illinois with coagulopathy and bleeding diathesis. Area physicians and public health organizations identified an association between coagulopathy and synthetic cannabinoid use. Preliminary tests of patient serum samples and drug samples revealed that brodifacoum, an anticoagulant, was the likely adulterant.. We reviewed physician-reported data from patients admitted to Saint Francis Medical Center in Peoria, Illinois, between March 28 and April 21, 2018, and included in a case series adult patients who met the criteria used to diagnose synthetic cannabinoid-associated coagulopathy. A confirmatory anticoagulant poisoning panel was ordered at the discretion of the treating physician.. A total of 34 patients were identified as having synthetic cannabinoid-associated coagulopathy during 45 hospitalizations. Confirmatory anticoagulant testing was performed in 15 of the 34 patients, and superwarfarin poisoning was confirmed in the 15 patients tested. Anticoagulant tests were positive for brodifacoum in 15 patients (100%), difenacoum in 5 (33%), bromadiolone in 2 (13%), and warfarin in 1 (7%). Common symptoms at presentation included gross hematuria in 19 patients (56%) and abdominal pain in 16 (47%). Computed tomography was performed to evaluate abdominal pain and revealed renal abnormalities in 12 patients. Vitamin K. Our data indicate that superwarfarin adulterants of synthetic cannabinoids can lead to clinically significant coagulopathy. In our series, in most of the cases in which the patient presented with bleeding diathesis, symptoms were controlled with the use of vitamin K

    Topics: 4-Hydroxycoumarins; Abdominal Pain; Adult; Anticoagulants; Blood Coagulation Disorders; Blood Transfusion; Cannabinoids; Female; Hematuria; Hemorrhage; Humans; Illinois; International Normalized Ratio; Male; Middle Aged; Patient Readmission; Vitamin K; Warfarin

2018
Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning.
    American journal of nephrology, 2015, Volume: 41, Issue:4-5

    Brodifacoum (BDF) is a superwarfarin that is used primarily as a rodenticide. There have been increasing numbers of reports of human cases of accidental or intentional BDF ingestion with high mortality rate. Its broad availability and high lethality suggest that BDF should be considered a potential chemical threat. Currently, there is no biomarker for early detection of BDF ingestion in humans; patients typically present with severe coagulopathy. Since we demonstrated earlier that warfarin can induce acute kidney injury with hematuria, we tested whether BDF would also lead to change in urinary biomarkers.. BDF was administered to Sprague Dawley rats via oral gavage. N-acetylcysteine (NAC) was given per os in drinking water 24 h prior to BDF. Urinalysis was performed at different times after BDF administration. Anticoagulation and serum creatinine levels were analyzed in the blood.. We observed that within a few hours the animals developed BDF-dose-dependent transient hemoglobinuria, which ceased within 24 h. This was accompanied by a transient decrease in hematocrit, gross hemolysis and an increase in free hemoglobin in the serum. At later times, animals developed true hematuria with red blood cells in the urine, which was associated with BDF anticoagulation. NAC prevented early hemoglobinuria, but not late hematuria associated with BDF.. We propose that transient early hemoglobinuria (associated with oxidative stress) with consecutive late hematuria (associated with anticoagulation) are novel biomarkers of BDF poisoning, and they can be used in clinical setting or in mass casualty with BDF to identify poisoned patients.

    Topics: 4-Hydroxycoumarins; Acetylcysteine; Animals; Biomarkers; Disease Progression; Free Radical Scavengers; Hematuria; Hemoglobins; Hemoglobinuria; Rats; Rats, Sprague-Dawley; Rodenticides

2015
Vitamin K treatment of brodifacoum poisoning in a pregnant woman.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013, Volume: 122, Issue:2

    Topics: 4-Hydroxycoumarins; Antifibrinolytic Agents; Female; Follow-Up Studies; Hematuria; Humans; Pregnancy; Rodenticides; Stillbirth; Vitamin K; Young Adult

2013
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.
    Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:10

    An acute increase in international normalized ratio (INR) to >3.0 in patients with chronic kidney disease (CKD) can associate with an unexplained acute increase in serum creatinine and accelerated progression of CKD. A subset of these patients have renal tubular obstruction by casts of red blood cells, presumably the dominant mechanism of the acute kidney injury described as warfarin-related nephropathy. Here, we developed an animal model of this acute kidney injury that is based on the 5/6-nephrectomy model to aid future investigation of the pathogenesis of this condition. We found that acute excessive anticoagulation with brodifacoum ("superwarfarin") increased serum creatinine levels and hematuria in 5/6-nephrectomized rats but not in controls. In addition, morphologic findings in 5/6-nephrectomized rats included glomerular hemorrhage, occlusive red blood cell casts, and acute tubular injury, similar to the biopsy findings among affected patients. Furthermore, in the rat model, we observed an increase in apoptosis of glomerular endothelial cells. In summary, the 5/6-nephrectomy model combined with excessive anticoagulation may be a useful tool to study the pathogenesis of warfarin-related nephropathy.

    Topics: 4-Hydroxycoumarins; Animals; Anticoagulants; Apoptosis; Disease Models, Animal; Endothelial Cells; Hematuria; Kidney; Kidney Diseases; Male; Nephrectomy; Rats; Rats, Sprague-Dawley

2011
Superwarfarin intoxication: hematuria is a major clinical manifestation.
    International journal of hematology, 2009, Volume: 90, Issue:2

    Since superwarfarin is popular and readily available in stores, it may cause intoxication or overexposure, which can result in coagulopathy or abnormal bleeding in humans and, thus, is an important public health problem. We report our clinical experience with superwarfarin intoxication. Nine patients, including eight patients who had histories of ingesting superwarfarin, were studied. Of the patients, hematuria occurred in eight. Laboratory tests among the nine patients showed extremely prolonged prothrombin times and activated partial thromboplastin times, which could be corrected to normal by mixing 1:1 with normal pooled plasma; they also had very low functional levels of factor II, VII, IX, X, and proteins C and S, but normal functional levels of factors V, VIII, fibrinogen, and anti-thrombin III. Large doses of vitamin K1 were needed for 3 months or more to treat and correct the coagulopathy among the patients. The majority of the patients presented with gross hematuria, suggesting that hematuria is probably a major clinical manifestation of superwarfarin intoxication. Prolonged use of large doses of vitamin K1 is needed for the treatment of superwarfarin intoxication.

    Topics: 4-Hydroxycoumarins; Adult; Aged; Blood Coagulation Tests; Female; Hematuria; Humans; Male; Middle Aged; Rodenticides; Suicide, Attempted; Vitamin K 1; Vitamins; Young Adult

2009
Rapid identification of surreptitious brodifacoum poisoning by analysis of vitamin K-dependent factor activity.
    The American journal of emergency medicine, 2006, Volume: 24, Issue:3

    Topics: 4-Hydroxycoumarins; Adult; Diagnosis, Differential; Hematuria; Humans; Male; Suicide, Attempted

2006
Surreptitious superwarfarin poisoning with brodifacoum.
    Southern medical journal, 1997, Volume: 90, Issue:10

    Because of the emergence of warfarin resistance in rodents, second-generation anticoagulants named "superwarfarins" were developed and marketed in over-the-counter rodenticide products. The availability of these compounds has resulted in accidental or intentional human ingestions, which cause severe bleeding. The methods for diagnosis and treatment of patients using superwarfarins are different from those for patients taking the regular warfarins. We report a case of intentional superwarfarin ingestion that caused petechiae and hematuria. Although the patient denied taking anticoagulant, the persistence of vitamin K-dependent factor deficiency led us to investigate the serum for anticoagulant rodenticides. We found high levels of brodifacoum, a superwarfarin compound. This case emphasizes the need for suspicion of superwarfarin poisoning in patients who show unexplained bleeding due to deficiency of vitamin K-dependent factors and resistance to treatment.

    Topics: 4-Hydroxycoumarins; Adult; Blood Coagulation Tests; Hematuria; Humans; Male; Poisoning; Rodenticides; Vitamin K Deficiency; Warfarin

1997